Atomwise
1 known investors
Atomwise uses artificial intelligence and machine learning to discover novel small-molecule drugs, with a current focus on developing treatments for immune and inflammatory diseases.
AI & Machine LearningBiotechDeep Tech
Investors · 1
In the news
- San Francisco's Atomwise raises $44 million in Series C round for AI drug discovery - San Francisco Business Timesbizjournals.com · 2025
- Exclusive: AI biotech Atomwise hires new CEO, raises $45M Series Cendpoints.news · 2025
- Atomwise - 2026 Company Profile, Team, Funding & Competitors - Tracxntracxn.com · 2021
- Atomwise Raises $123 Million to Accelerate AI Drug Discovery | NVIDIA Technical Blogdeveloper.nvidia.com · 2020
- Atomwise secures $123 million in funding to help ‘drug the undruggable’ | AI Businessaibusiness.com · 2020
- Deep learning startup Atomwise raises $45Mtechcrunch.com · 2018